Reported MS prevalence rates in the Middle East are low.
Few studies include age/sex standardization giving unreliable prevalence estimates.
A retrospective chart review of MS in Abu Dhabi was conducted.
At 64.44/100,000, the Abu Dhabi Emirati population has a high Arab prevalence rate.
Age/sex standardized prevalence rates should be standard for all prevalence studies.